HMGB1 and cancer: To extend the in vivo discovery in cancer cells, we have undertaken a different HMGB1-interactome analysis approach based on immunoprecipitation (IP) and mass spectrometry (MS) in PC-3 and SKOV-3 cell lines that represent models for prostate and ovarian cancer, respectively.